stocks logo

CTOR Valuation

Citius Oncology Inc
$
0.641
-0.029(-4.330%)
  • Overview
  • Forecast
  • Valuation

CTOR Relative Valuation

CTOR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CTOR is overvalued; if below, it's undervalued.

Historical Valuation

P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.16
P/B
Median3y
18.78
Median5y
18.78
0.27
FCF Yield
Median3y
0.04
Median5y
0.04

Competitors Valuation Multiple

The average P/S ratio for CTOR's competitors is 1.77, providing a benchmark for relative valuation. Citius Oncology Inc Corp (CTOR) exhibits a P/S ratio of 1.04, which is -41.36% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
stocks logo
CTOR.O
Citius Oncology Inc
1.04
Average P/S: 1.77
45.87M
stocks logo
MIST.O
Milestone Pharmaceuticals Inc
Loss
67.23M
stocks logo
OTLK.O
Outlook Therapeutics Inc
3.20
50.56M
stocks logo
APLT.O
Applied Therapeutics Inc
6.40
56.39M
stocks logo
PDSB.O
PDS Biotechnology Corp
Loss
59.92M
stocks logo
AVTX.O
Avalo Therapeutics Inc
Loss
-66.37%
52.08M

People Also Watch

stocks logo
CAN
Canaan Inc
0.800
USD
+1.01%
stocks logo
CLMB
Climb Global Solutions Inc
107.590
USD
+2.76%
stocks logo
ABUS
Arbutus Biopharma Corp
3.340
USD
+3.09%
stocks logo
CCBG
Capital City Bank Group Inc
36.870
USD
+0.19%
stocks logo
CTO
CTO Realty Growth Inc
17.990
USD
-0.83%
stocks logo
CGEM
Cullinan Oncology Inc
8.140
USD
-2.86%
stocks logo
KRT
Karat Packaging Inc
25.910
USD
+4.50%
stocks logo
LEGH
Legacy Housing Corp
24.890
USD
+1.14%
stocks logo
WEST
Westrock Coffee Co
5.730
USD
-2.72%
stocks logo
CION
Cion Investment Corp
9.980
USD
+1.11%

FAQ

arrow icon

Is Citius Oncology Inc (CTOR) currently overvalued or undervalued?

Citius Oncology Inc (CTOR) is now in the Fair zone, suggesting that its current forward PS ratio of 1.04 is considered Fairly compared with the five-year average of 0.71. The fair price of Citius Oncology Inc (CTOR) is between to according to relative valuation methord.
arrow icon

What is Citius Oncology Inc (CTOR) fair value?

arrow icon

How does CTOR's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Citius Oncology Inc (CTOR) as of Apr 25 2025?

arrow icon

What is the current FCF Yield for Citius Oncology Inc (CTOR) as of Apr 25 2025?

arrow icon

What is the current Forward P/E ratio for Citius Oncology Inc (CTOR) as of Apr 25 2025?

arrow icon

What is the current Forward P/S ratio for Citius Oncology Inc (CTOR) as of Apr 25 2025?